Dr. David L Shuster MD

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

Pleurisy is the inflammation of the two membranes that line your lungs. Both your lungs are lined by a thin membrane called the pleura. One layer is lining your lungs and the other is lining the inside of your chest wall. Between these two membranes is a small cavity known as the pleural cavity. It...

Cystic fibrosis is a genetic disease that mainly affects the lungs, liver, pancreas, intestines, reproductive organs, and sinuses. It causes thick and sticky mucus to accumulate and clog the lungs, making it difficult to breathe and resulting in persistent lung infections and lung damage. The...

What is chronic bronchitis?Chronic bronchitis is defined as a persistent cough with sputum production for at least three months in at least two consecutive years in the absence of any other identifiable causes.Chronic bronchitis is also commonly known as the smoker’s cough. This is due to the fact...

In the United States, there are currently 30,000 individuals living with cystic fibrosis - a progressive, hereditary condition that results in persistent lung infections and airway obstruction, making it difficult to breathe. There is no cure for cystic fibrosis, although there are several treatment...

Every day, people coping with cystic fibrosis (CF) strive to live their lives to the fullest, from exercising and managing their everyday care to tackling obstacles head-on and raising awareness. Throughout the years, CF communities have been making their mark and pushing for better care. Today,...